Clinical and immunopathological features of patients with lupus hepatitis

Chinese Medical Journal

Volumn 126, Issue 2, 2013, Pages 260-266

  Zheng, Ru hua ^a   Wang, Jin hui ^a   Wang, Shu bing ^a   Chen, Jie ^a   Guan, Wei ming ^a   Chen, Min hu ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

Immunopathology; Injury; Liver; Lupus

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; COMPLEMENT COMPONENT C1Q; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; FLUORESCEIN ISOTHIOCYANATE; GAMMA GLUTAMYLTRANSFERASE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE TEST; INCIDENCE; LEUKOCYTE COUNT; LUPOID HEPATITIS; MALE; PREVALENCE; RETROSPECTIVE STUDY; SLEDAI; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOCYTE COUNT;

ADOLESCENT; ADULT; AGED; CHILD; COHORT STUDIES; COMPLEMENT C1Q; FEMALE; HEPATITIS, AUTOIMMUNE; HUMANS; LIVER; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 84875721430     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.20121153     Document Type: Article

References (33)

1. Piga M, Vacca A, Porru G, Garau P, Cauli A, Mathieu A. Two different clinical subsets of lupus hepatitis exist. Mimicking primary autoimmune liver diseases or part of their spectrum? Lupus 2011; 20: 1450-1451.
2. Piga M, Vacca A, Porru G, Cauli A, Mathieu A. Liver involvement in systemic lupus erythematosus: incidence, clinical course and outcome of lupus hepatitis. Clin Exp Rheumatol 2010; 28: 504-510.
3. Khalifa M, Benjazia E, Rezgui A, Ghannouchi N, Alaoua A, Braham A, et al. Lupus hepatitis: a case series of 12 patients. Rev Med Interne 2011; 32: 347-349.
4. Weening JJ, D'Agati VD, Schwartz MM, Seshan SV, Alpers CE, Appel GB, et al. The classification of glomerulonephritis in systemic lupus erythematosus revisited. J Am Soc Nephrol 2004; 15: 241-250.
5. Her M, Lee Y, Jung E, Kim T, Kim D. Liver enzyme abnormalities in systemic lupus erythematosus: a focus on toxic hepatitis. Rheumatol Int 2011; 31: 79-84.
6. Deen ME, Porta G, Fiorot FJ, Campos LM, Sallum AM, Silva CA. Autoimmune hepatitis and juvenile systemic lupus erythematosus. Lupus 2009; 18: 747-751.
7. Sonomoto K, Miyamura T, Watanabe H, Takahama S, Nakamura M, Ando H, et al. A case of systemic lupus erythematosus complicated with autoimmune hepatitis and thrombotic thrombocytic purpura. Nihon Rinsho Meneki Gakkai Kaishi 2009; 32: 110-115.
8. Hahn BH, McMahon MA, Wilkinson A, Wallace WD, Daikh DI, Fitzgerald JD, et al. American College of Rheumatology. American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis. Arthritis Care Res (Hoboken) 2012; 64: 797-808.
9. Markowitz GS, D'Agati VD. Classification of lupus nephritis. Curr Opin Nephrol Hypertens 2009; 18: 220-225.
10. Baskin E, Agras PI, Menekşe N, Ozdemir H, Cengiz N. Full-house nephropathy in a patient with negative serology for lupus. Rheumatol Int 2007; 27: 281-284.
11. Gianviti A, Barsotti P, Barbera V, Faraggiana T, Rizzoni G. Delayed onset of systemic lupus erythematosus in patients with "full-house" nephropathy. Pediatr Nephrol 1999; 13: 683-687.
12. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997; 40: 1725.
13. Gladman DD, Ibanez D, Urowitz MB. Systemic lupus erythematosus disease activity index 2000. J Rheumatol 2002; 29: 288-291.
14. Renal Disease Subcommittee of the American College of Rheumatology Ad Hoc Committee on Systemic Lupus Erythematosus Response Criteria. The American College of Rheumatology response criteria for proliferative and membranous renal disease in systemic lupus erythematosus clinical trials. Arthritis Rheum 2006; 54: 421-432.
15. Harvey AM, Shulman LE, Tumulty PA, Conley CL, Schoenrich EH. Systemic lupus erythematosus: review of the literature and clinical analysis of 138 cases. Medicine (Baltimore) 1954; 33: 291-437.
16. Huang D, Aghdassi E, Su J, Mosko J, Hirschfield GM, Gladman DD, et al. Prevalence and risk factors for liver biochemical abnormalities in Canadian patients with systemic lupus erythematosus. J Rheumatol 2012; 39: 254-261.
17. Mackay IR, Taft LJ, Cowling DC. Lupoid hepatitis and the hepatic lesions of systemic lupus erythematosus. Lancet 1959; 1: 65-69.
18. Dubois EL, Tuffaneli DL. Clinical manifestations of systemic lupus erythematosus: computer analysis of 520 patients. JAMA 1964; 190: 104-111.
19. Chowdhary VR, Crowson CS, Poterucha JJ, Moder KG. Liver involvement in systemic lupus erythematosus: case review of 40 patients. J Rheumatol 2008; 35: 2159-2164.
20. Leggett BA. The liver in systemic lupus erythematosus. J Gastroenterol Hepatol 1993; 8: 84-88.
21. Ebert EC, Hagspiel KD. Gastrointestinal and hepaticmanifestations of systemic lupus erythematosus. J Clin Gastroenterol 2011; 45: 436-441.
22. Irving KS, Sen D, Tahir H, Pilkington C, Isenberg DA. A comparison of autoimmune liver disease in juvenile and adult populations with systemic lupus erythematosus-a retrospective review of cases. Rheumatology (Oxford) 2007; 46: 1171-1173.
23. Alvarez F, Berg PA, Bianchi FB, Bianchi L, Burroughs AK, Cancado EL, et al. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 1999; 31: 929-938.
24. Gurian LE, Rogoff TM, Ware AJ, Jordan RE, Combes B, Gilliam JN. The immunologic diagnosis of chronic active "autoimmune" hepatitis: distinction from systemic lupus erythematosus. Hepatology 1985; 5: 397-402.
25. Efe C, Purnak T, Ozaslan E, Ozbalkan Z, Karaaslan Y, Altiparmak E, et al. Autoimmune liver disease in patients with systemic lupus erythematosus: a retrospective analysis of 147 cases. Scand J Gastroenterol 2011; 46: 732-737.
26. Efe C, Purnak T, Ozaslan E, Ozbalkan Z. The importance of autoimmune hepatitis and primary biliary cirrhosis in patients with systemic lupus erythematosus. Lupus 2011; 20: 112.
27. González LA, Orrego M, Ramírez LA, Vásquez G. Primary biliary cirrhosis/autoimmune hepatitis overlap syndrome developing in a patient with systemic lupus erythematosus: a case report and review of the literature. Lupus 2011; 20: 108-111.
28. Ramos-Casals M, Cuadrado MJ, Alba P, Sanna G, Brito-Zerón P, Bertolaccini L, et al. Acute viral infections in patients with systemic lupus erythematosus: description of 23 cases and review of the literature. Medicine (Baltimore) 2008; 87: 311-318.
29. Hahn BH, McMahon MA, Wilkinson A, Wallace WD, Daikh DI, Fitzgerald JD, et al. American College of Rheumatology. American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis. Arthritis Care Res (Hoboken) 2012; 64: 797-808.
30. Jennette JC, Iskandar SS, Dalldorf FG. Pathologic differentiation between lupus and nonlupus membranous glomerulopathy. Kidney Int 1983; 24: 377-385.
31. Jennette JC, Hipp CG. Immunohistopathologic evaluation of C1q in 800 renal biopsy specimens. Am J Clin Pathol 1985; 83: 415-420.
32. Zhang FC, Zhou B, Dong Y. The roles of complement 1q and anti-C1q autoantibodies in pathogenesis of lupus nephritis. Natl Med J China (Chin) 2005; 85: 955-999.
33. Kessenbrock K, Fritzler MJ, Groves M, Eissfeller P, von Mühlen CA, Höpfl P, et al. Diverse humoral autoimmunity to the ribosomal P proteins in systemic lupus erythematosus and hepatitis C virus infection. J Mol Med (Berl) 2007; 85: 953-959.